Triochem Products Complete Financial Statements
In FYNone, Triochem Products (TRIPR) reported revenue ₹12 Cr, net profit ₹8 Cr and EPS ₹330.50, with a net profit margin of 800.0% and ROE of 38.1%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Analyse TRIPR institutional holdings to track promoter, FII and institutional holdings.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
TRIPR Revenue, Net Profit & EBITDA — Year-on-Year Growth
TRIPR YoY (March 2026 vs Period) — revenue +1100.0%, EBITDA +1200.0%. Also explore TRIPR stock price history to track price trends across different timeframes.
TRIPR Income Statement — Revenue, EBITDA & Net Profit
Triochem Products revenue ₹12 Cr, EBITDA ₹11 Cr, net profit ₹8 Cr, EPS ₹330.50 (None) — net profit margin 800.0%. For live price, earnings ratios and company overview, see TRIPR stock price BSE.
| Particulars | None | March 2026 | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12 | 1 | 1 | 1 | 0 | 9 | 14 | 21 | 12 | 35 | 18 | 23 | 31 |
| Expenses | 1 | 1 | 1 | 1 | 1 | 8 | 14 | 16 | 11 | 31 | 17 | 22 | 30 |
| EBITDA | 11 | -1 | 0 | 0 | -1 | 2 | 0 | 5 | 2 | 4 | 1 | 1 | 1 |
| Operating Profit Margin % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 15.00% | -3.00% | 22.00% | 13.00% | 11.00% | 5.00% | 4.00% | 4.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 11 | 11 | 0 | -1 | -1 | 2 | -1 | 5 | 1 | 4 | 1 | 1 | 1 |
| Tax | 2 | 3 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 |
| Net Profit | 8 | 8 | 0 | -1 | -1 | 1 | 0 | 3 | 1 | 3 | 1 | 0 | 0 |
| Earnings Per Share (₹) | 330.50 | 325.34 | -16.33 | -41.36 | -36.12 | 53.99 | -18.24 | 138.89 | 30.33 | 104.29 | 23.51 | 13.94 | 16.98 |
TRIPR Balance Sheet — Assets, Liabilities & Shareholders' Equity
TRIPR total assets ₹21 Cr, total equity ₹21 Cr, total liabilities ₹ Cr (2026) — ROE 38.1%.
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Total Assets | 21 | 14 | 15 | 12 | 13 | 12 | 17 | 15 | 12 | 10 | 7 | 9 |
| Current Assets | 13 | 3 | 3 | 1 | 12 | 11 | 15 | 14 | 10 | 8 | 1 | 6 |
| Fixed Assets | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 8 | 11 | 11 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 13 | 3 | 3 | 2 | 13 | 11 | 16 | 14 | 10 | 9 | 5 | 6 |
| LIABILITIES | ||||||||||||
| Total Liabilities | ||||||||||||
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | ||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||
| Total Equity | 21 | 14 | 15 | 12 | 13 | 12 | 12 | 9 | 8 | 6 | 5 | 5 |
| Share Capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves & Surplus | 20 | 13 | 14 | 11 | 13 | 12 | 12 | 9 | 8 | 5 | 5 | 4 |
TRIPR Cash Flow Statement — Operating, Investing & Financing
Triochem Products operating cash flow ₹-3 Cr, investing ₹14 Cr, financing ₹0 Cr, net cash flow ₹11 Cr (2026).
| Particulars | March 2026 | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -3 | 0 | -4 | -1 | 4 | 10 | 4 | -4 | 2 | -7 | 7 | 2 |
| Investing Activities | 14 | 0 | 3 | -10 | 0 | 0 | 0 | 0 | 0 | 4 | -4 | 0 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | -3 | -4 | 3 | -1 | 3 | -4 | -2 |
| Net Cash Flow | 11 | 0 | 0 | -11 | 4 | 8 | 0 | -1 | 1 | 0 | -1 | 1 |